- Home
- GOCO vs ARMP Comparison
GOCO vs ARMP Comparison
Compare GOCO & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOCO
- ARMP
- Stock Information
- Founded
- GOCO 2001
- ARMP N/A
- Country
- GOCO United States
- ARMP United States
- Employees
- GOCO N/A
- ARMP N/A
- Industry
- GOCO Specialty Insurers
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GOCO Finance
- ARMP Health Care
- Exchange
- GOCO Nasdaq
- ARMP Nasdaq
- Market Cap
- GOCO 64.9M
- ARMP 52.1M
- IPO Year
- GOCO 2020
- ARMP N/A
- Fundamental
- Price
- GOCO $6.00
- ARMP $2.38
- Analyst Decision
- GOCO Hold
- ARMP Strong Buy
- Analyst Count
- GOCO 1
- ARMP 1
- Target Price
- GOCO $18.00
- ARMP $9.00
- AVG Volume (30 Days)
- GOCO 34.8K
- ARMP 14.6K
- Earning Date
- GOCO 08-07-2025
- ARMP 08-12-2025
- Dividend Yield
- GOCO N/A
- ARMP N/A
- EPS Growth
- GOCO N/A
- ARMP N/A
- EPS
- GOCO N/A
- ARMP N/A
- Revenue
- GOCO $834,266,000.00
- ARMP $4,699,000.00
- Revenue This Year
- GOCO $8.51
- ARMP $8.43
- Revenue Next Year
- GOCO $7.19
- ARMP N/A
- P/E Ratio
- GOCO N/A
- ARMP N/A
- Revenue Growth
- GOCO 13.18
- ARMP 14.24
- 52 Week Low
- GOCO $5.01
- ARMP $0.90
- 52 Week High
- GOCO $21.00
- ARMP $3.00
- Technical
- Relative Strength Index (RSI)
- GOCO 49.27
- ARMP 58.88
- Support Level
- GOCO $5.60
- ARMP $2.14
- Resistance Level
- GOCO $6.31
- ARMP $2.61
- Average True Range (ATR)
- GOCO 0.34
- ARMP 0.16
- MACD
- GOCO 0.04
- ARMP -0.00
- Stochastic Oscillator
- GOCO 44.44
- ARMP 60.34
About GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.